Market Research Logo

Lantheus Medical Imaging Inc - Product Pipeline Analysis, 2018 Update

Summary

Lantheus Medical Imaging Inc (Lantheus Medical), a subsidiary of Lantheus Holdings, Inc., develops, manufactures, and commercializes diagnostic imaging agents and products for the diagnosis of conditions that affect heart, brain, lungs and other organs using echocardiography and nuclear imaging. The company’s major products include ultrasound contrast agents, inhalable and injectable radiopharmaceutical imaging agents, and technetium-based generators. Its products are used to diagnose coronary artery disease, stroke, congestive heart failure, cancerous tumors and other diseases. Lantheus Medical develops its products using positron emission tomography and magnetic resonance imaging technologies. The company offers its products to nuclear physicians, internal medicine physicians, cardiologists, radiologists, technologists and sonographers. Lantheus Medical is headquartered in North Billerica, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Lantheus Medical Imaging Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Lantheus Medical Imaging Inc Company Overview
Lantheus Medical Imaging Inc Company Snapshot 5
Lantheus Medical Imaging Inc Pipeline Products and Ongoing Clinical Trials Overview
Lantheus Medical Imaging Inc – Pipeline Analysis Overview 7
Business Description 7
Lantheus Medical Imaging Inc - Key Facts 7
Lantheus Medical Imaging Inc - Major Products and Services 8
Lantheus Medical Imaging Inc Pipeline Products by Development Stage 9
Lantheus Medical Imaging Inc Ongoing Clinical Trials by Trial Status 11
Lantheus Medical Imaging Inc Pipeline Products Overview 14
DEFINITY 14
DEFINITY Product Overview 14
DEFINITY Clinical Trial 15
Flurpiridaz F 18 26
Flurpiridaz F 18 Product Overview 26
LMI 1174 27
LMI 1174 Product Overview 27
LMI 1195 28
LMI 1195 Product Overview 28
Next-Generation DEFINITY 29
Next-Generation DEFINITY Product Overview 29
Lantheus Medical Imaging Inc - Key Competitors 30
Lantheus Medical Imaging Inc - Key Employees 31
Lantheus Medical Imaging Inc - Key Employee Biographies 32
Lantheus Medical Imaging Inc - Locations And Subsidiaries 33
Head Office 33
Recent Developments 34
Lantheus Medical Imaging Inc, Recent Developments 34
May 02, 2018: Lantheus Holdings Announces 2018 First Quarter Financial Results 34
Mar 12, 2018: Lantheus Presents New Data on Novel Cardiac PET Imaging Agent LMI 1195 in Development for the Diagnostic Assessment of Ischemic Heart Failure Patients at Risk for Sudden Cardiac Death at ACC.18 34
Feb 27, 2018: Lantheus Holdings Names Gary Pruden, Kenneth Pucel and Dr. James Thrall to its Board of Directors 35
Nov 02, 2017: Lantheus Holdings Reports 2017 Third Quarter Financial Results; Exceeds Third Quarter and Raises Full-Year 2017 Guidance 36
May 02, 2017: Lantheus Holdings Reports 2017 First Quarter Financial Results; Exceeds First Quarter and Raises Full-Year 2017 Guidance 36
Mar 30, 2017: Lantheus Announces Refinancing of its Debt Facility 37
Feb 21, 2017: Lantheus Holdings Reports 2016 Fourth Quarter and Full Year Financial Results; Provides 2017 Guidance 38
Feb 02, 2017: Lantheus Medical Imaging Announces FDA Approval of DEFINITY Label Update 38
Jan 26, 2017: Lantheus Holdings Appoints New Member to its Board of Directors 39
Nov 01, 2016: Lantheus Holdings Reports 2016 Third Quarter Financial Results 39
Appendix 41
Methodology 41
About GlobalData 44
Contact Us 44
Disclaimer 44
List of Tables
Lantheus Medical Imaging Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Lantheus Medical Imaging Inc Pipeline Products by Equipment Type 6
Lantheus Medical Imaging Inc Pipeline Products by Indication 6
Lantheus Medical Imaging Inc Ongoing Clinical Trials by Trial Status 6
Lantheus Medical Imaging Inc, Key Facts 7
Lantheus Medical Imaging Inc, Major Products and Services 8
Lantheus Medical Imaging Inc Number of Pipeline Products by Development Stage 9
Lantheus Medical Imaging Inc Pipeline Products Summary by Development Stage 10
Lantheus Medical Imaging Inc Ongoing Clinical Trials by Trial Status 11
Lantheus Medical Imaging Inc Ongoing Clinical Trials Summary 12
DEFINITY - Product Status 14
DEFINITY - Product Description 14
DEFINITY - 2D and 4D Contrast-enhanced Ultrasound Evaluation of Hepatocellular Carcinoma Chemoembolization 15
DEFINITY - Aortic Wall Behavior as a Predictor of Aortic Aneurysm Growth and Rupture 15
DEFINITY - Assessment of the Changes in Cortical and Medullary Renal Blood Flow During Exercise in Healthy Subjects Using Contrast Enhanced Ultrasound 15
DEFINITY - Augmentation of Limb Perfusion with Contrast Ultrasound 16
DEFINITY - Comparison of the Sensitivity and Specificity of Acoustic Angiography (Micro-tumor Detection by Quantifying Tumor-induced Vascular Abnormalities) to the Sensitivity and Specificity of Conventional Ultrasound 16
DEFINITY - Contrast Enhanced Intracardiac Echocardiography (ICE) for Localization of Myocardial Scar During Ablation of Ventricular Tachycardia 16
DEFINITY - Contrast Enhanced Voiding Urosonography (ceVUS) with the Intravesical Administration of the Ultrasound Contrast Agent OPTISON for Vesicoureteral Reflux Detection and Urethral Imaging in Children 17
DEFINITY - Contrast-enhanced Ultrasound for Complex Kidney Lesion Diagnosis in Patients with CKD (CEUS CKD) 17
DEFINITY - Contrast-enhanced Ultrasound for Complex Kidney Lesion Diagnosis in Patients with CKD Extension: CEUS CKDx 17
DEFINITY - Contrast-enhanced Ultrasound for Follow-up after Radiofrequency Ablation of Renal Lesions: A Prospective, Blinded Study 18
DEFINITY - Detection of High Grade Prostate Cancer with Subharmonic Ultrasound Imaging: A Pilot Study 18
DEFINITY - Perflutren Protein-Type A Microspheres and Contrast-enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients with Liver Cancer 19
DEFINITY - Peripheral Blood Flow Responses to Electromagnetic Energy 20
DEFINITY - Pilot-Study - Incorporating Contrast-enhanced Ultrasound (CEUS) to Real-time MRI / Ultrasound Fusion Imaging for Prostate Biopsies 20
DEFINITY - Prospective Analysis and Comparison of Conventional Stress Echocardiograms and Real-Time Myocardial Contrast Stress Echocardiogram; for Bristol-Myers Squibb Medical Imaging: The Definity RT-P During DSE Database 20
DEFINITY - Quantitative Subharmonic Breast Imaging 21
DEFINITY - Quantitative Subharmonic Breast Imaging: Subharmonic Imaging and Pressure Estimation for Monitoring Neoadjuvant Chemotherapy 21
DEFINITY - Real Time Contrast Enhanced Ultrasound and Ultrasound-based Elastography: Novel Techniques in Assessment of Treatment Response to Neoadjuvant Chemotherapy for Breast Cancer 21
DEFINITY - Real Time Myocardial Perfusion Echocardiography for Detection of Coronary Allograft Vasculopathy in Cardiac Transplant Patients: RTMPE for CAV 22
DEFINITY - Real-time Contrast Enhanced Ultrasound and Ultrasound-based Elastography: Novel Quantitative Imaging Techniques for Early Therapy Response Assessment in Sarcomas 22
DEFINITY - Safety and Feasibility of Primary Motor Cortex Blood-brain Barrier Opening Using Transcranial MR-Guided Focused Ultrasound with Intravenous Ultrasound Contrast Agent in Patients with Amyotrophic Lateral Sclerosis 23
DEFINITY - Sonothrombolysis in Patients with an ST-segment Elevation Myocardial Infarction. A Prospective Single-arm Study 23
DEFINITY - The Impact of Real-time Myocardial Perfusion Echocardiography on Diagnostic Confidence and Subsequent Management of Myocardial Ischemia in the Intensive Care Unit: RTMPE in the ICU 23
DEFINITY - The Role of Aldosterone on Sympathetic Nerve Activity and Insulin Sensitivity 24
DEFINITY - The Use of Optison Echocardiography Contrast in the Detection of Left Atrial Appendage Thrombus with Transesophageal Echocardiography 24
DEFINITY - Therapeutic Use of Ultrasound in Acute Coronary Artery Disease 24
DEFINITY - Use of Definity Contrast Agent for Ultrasound of Intraocular Tumors 25
DEFINITY - Use of Reactivated DEFINITY in Patients Undergoing Stress Echo 25
DEFINITY - Vasodilatory Effects of Light on Peripheral Artery Disease 25
Flurpiridaz F 18 - Product Status 26
Flurpiridaz F 18 - Product Description 26
LMI 1174 - Product Status 27
LMI 1174 - Product Description 27
LMI 1195 - Product Status 28
LMI 1195 - Product Description 28
Next-Generation DEFINITY - Product Status 29
Next-Generation DEFINITY - Product Description 29
Lantheus Medical Imaging Inc, Key Employees 31
Lantheus Medical Imaging Inc, Key Employee Biographies 32
Glossary 43
List of Figures
Lantheus Medical Imaging Inc Pipeline Products by Equipment Type 6
Lantheus Medical Imaging Inc Pipeline Products by Development Stage 9
Lantheus Medical Imaging Inc Ongoing Clinical Trials by Trial Status 11

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report